The monoclonal antibody nirsevimab (Beyfortus) has shown promising results in protecting young infants against severe outcomes related to respiratory syncytial virus (RSV) infection. According to the French ENVIE study, nirsevimab was estimated to be 83% effective in preventing hospitalization from RSV bronchiolitis in infants younger than 12 months of age. The study also found that
0 Comments
The Federal Trade Commission is gearing up to file lawsuits against three major U.S. health companies for their practices as middlemen in negotiating medication prices. The companies in question include UnitedHealth Group’s Optum Rx, CVS Health’s Caremark, and Cigna’s Express Scripts. These companies are connected to health insurers and are accused of inflating costs for
0 Comments
A bipartisan group of senators recently initiated a fresh attempt to prohibit members of Congress from engaging in stock trading. This proposal aims to address concerns regarding lawmakers profiting from privileged information and gaining an unfair advantage in the market. The proposed legislation would immediately prevent members of Congress, the president, and the vice president
0 Comments